CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 47 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $182,000 | +14.5% | 33,106 | +4.3% | 0.00% | – |
| Q3 2016 | $159,000 | +11.2% | 31,743 | -0.3% | 0.00% | – |
| Q2 2016 | $143,000 | -2.1% | 31,842 | -1.9% | 0.00% | – |
| Q1 2016 | $146,000 | -21.1% | 32,464 | -7.7% | 0.00% | – |
| Q4 2015 | $185,000 | -5.6% | 35,156 | +3.2% | 0.00% | – |
| Q3 2015 | $196,000 | -21.6% | 34,052 | -2.6% | 0.00% | – |
| Q2 2015 | $250,000 | -10.4% | 34,952 | -16.5% | 0.00% | – |
| Q1 2015 | $279,000 | +4.5% | 41,868 | -6.3% | 0.00% | – |
| Q4 2014 | $267,000 | +30.2% | 44,700 | +7.7% | 0.00% | – |
| Q3 2014 | $205,000 | +2.5% | 41,514 | -6.8% | 0.00% | – |
| Q2 2014 | $200,000 | +2.6% | 44,523 | +2.9% | 0.00% | – |
| Q1 2014 | $195,000 | +0.5% | 43,251 | +13.8% | 0.00% | – |
| Q4 2013 | $194,000 | +17.6% | 38,004 | +4.4% | 0.00% | – |
| Q3 2013 | $165,000 | -3.5% | 36,414 | +8.5% | 0.00% | – |
| Q2 2013 | $171,000 | – | 33,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 286,655 | $541,778 | 0.01% |
| Renaissance Technologies | 555,763 | $1,050 | 0.00% |
| Oakworth Capital, Inc. | 3,052 | $5,768 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 188,164 | $354 | 0.00% |
| MORGAN STANLEY | 11,274 | $21,308 | 0.00% |
| BlackRock Inc. | 110,990 | $209,771 | 0.00% |
| Bank of New York Mellon Corp | 75,268 | $142,256 | 0.00% |
| Citadel Advisors | 32,400 | $61,236 | 0.00% |
| Citadel Advisors | 6,400 | $12,096 | 0.00% |
| Citadel Advisors | 5,933 | $11,213 | 0.00% |